Literature DB >> 19302175

Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection.

Maria Pino1, David J Kelvin, Jesus F Bermejo-Martin, Ana Alonso, Vanesa Matías, Alberto Tenorio, Lucia Rico, Jose M Eiros, J Castrodeza, Alfredo Blanco-Quiros, Julio Ardura, Raul Ortiz de Lejarazu.   

Abstract

Respiratory syncytial virus (RSV) infection is an important cause of recurrent wheezing in infants. Nevertheless, the link between RSV infection and wheezing has yet to be elucidated at the molecular level. Here, we present a preliminary study on the evolution of the immune response in the respiratory tract at long-term after RSV infection. Twenty-seven immune mediators were profiled in nasopharyngeal aspirates (NPAs) obtained from 20 children hospitalized due to a severe infection by RSV at discharge from hospital and again 1 yr later. The same mediators were profiled in parallel in NPAs from 12 healthy controls. In the year following discharge, 85% (17/20) of children of the RSV group suffered at least one episode of wheezing documented by the pediatrician. On the contrary, wheezing episodes were observed only in 25% (3/12) of children in the control group. While most of the mediators profiled returned to normal levels by 1 yr after discharge from hospital, RSV children showed a persistent nasal hyper-secretion of VEGF, G-CSF, IL-10, IL-6, IFN-gamma, IL-7 and IL-13. In previous works VEGF, IL-10 and IFN-gamma have been put in relation with the pathogenesis of post-virus induced asthma. G-CSF, IL-6, IL-7 and IL-13 are increased in respiratory and plasma samples of asthmatic patients. Here, we evidence for the first time a persistent elevation of these mediators as late as 1 yr after severe RSV disease resolution, reinforcing their possible implication in the pathogenesis of wheezing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302175     DOI: 10.1111/j.1399-3038.2009.00868.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  9 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles.

Authors:  David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

3.  Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.

Authors:  Alicia K Olivier; Jack M Gallup; Albert van Geelen; Mark R Ackermann
Journal:  Exp Lung Res       Date:  2011-02-11       Impact factor: 2.459

4.  Cytokine responses in primary and secondary respiratory syncytial virus infections.

Authors:  Kelechi Ugonna; Konstantinos Douros; Colin D Bingle; Mark L Everard
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 5.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

6.  Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.

Authors:  Rémi Villenave; Dara O'Donoghue; Surendran Thavagnanam; Olivier Touzelet; Grzegorz Skibinski; Liam G Heaney; James P McKaigue; Peter V Coyle; Michael D Shields; Ultan F Power
Journal:  Virol J       Date:  2011-01-27       Impact factor: 4.099

Review 7.  Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection.

Authors:  Karen Bohmwald; Nicolás M S Gálvez; Gisela Canedo-Marroquín; Magdalena S Pizarro-Ortega; Catalina Andrade-Parra; Felipe Gómez-Santander; Alexis M Kalergis
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

8.  Titanium dioxide nanoparticles exaggerate respiratory syncytial virus-induced airway epithelial barrier dysfunction.

Authors:  Carrie C Smallcombe; Terri J Harford; Debra T Linfield; Susana Lechuga; Vladimir Bokun; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-08       Impact factor: 5.464

Review 9.  Mucosal Immune Responses to Respiratory Syncytial Virus.

Authors:  Megan V C Barnes; Peter J M Openshaw; Ryan S Thwaites
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.